CNTB: Connect Biopharma Holdings Limited - American Depositary Shares

2.10 USD 0.26 (14.13%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

CNTB exchange rate has changed by 14.13% for today. During the day, the instrument was traded at a low of 1.73 and at a high of 2.11.

Follow Connect Biopharma Holdings Limited - American Depositary Shares dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

CNTB News

Zacks 16:00 What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?
Investing 13:45 Connect Biopharma stock rating reiterated as Outperform by Northland
Investing 13:32 Connect Biopharma appoints Jim Schoeneck to board of directors
Investing 13:17 Connect Biopharma appoints James A. Schoeneck to board of directors
Investing 13:52 Connect Biopharma stock rises after announcing plan to terminate ADR program
Investing 13:16 Connect Biopharma to terminate ADR program, list ordinary shares
Investing 13:31 Connect Biopharma regains Nasdaq compliance with minimum bid price rule
Investing 13:07 Connect Biopharma regains Nasdaq compliance with $1 minimum bid price
Investing 13:13 Connect Biopharma’s partner submits new drug application in China
Investing 13:05 Connect Biopharma reports positive data for asthma treatment
Investing 13:52 Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
Investing 13:40 Connect Biopharma to Present at Two Upcoming Investor Conferences in June
Investing 13:32 Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference
Investing 13:52 Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update
Investing 13:27 Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD

Daily Range

1.73 2.11

Year Range

0.51 2.86

Previous Close: 1.75
Open: 1.84

Bid: 2.10
Ask: 2.40

Low: 1.73
High: 2.11

Volume: 450

Daily Change: 14.13%
Month Change: 101.92%

6 Months Change: 116.49%
Year Change: 77.97%

31 July, Thursday